{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:45:49Z","timestamp":1761821149032,"version":"3.41.2"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1023\/a:1014643528474","type":"journal-article","created":{"date-parts":[[2002,12,28]],"date-time":"2002-12-28T16:18:52Z","timestamp":1041092332000},"page":"213-229","source":"Crossref","is-referenced-by-count":27,"title":["Vigabatrin; its effect on the electrophysiology of vision"],"prefix":"10.1007","volume":"104","author":[{"given":"G.F.A.","family":"Harding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.L.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Holliday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"360484_CR1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bmj.314.7075.180","volume":"314","author":"T Eke","year":"1997","unstructured":"Eke T, Talbot J, Lawden MC. Severe persistent visual field constriction associated with vigabatrin. Br Med J 1997; 314: 180\u2013181.","journal-title":"Br Med J"},{"key":"360484_CR2","first-page":"105","volume":"15","author":"MT Faeda","year":"1993","unstructured":"Faeda MT, Giallonardo, AT, Marchetti A, Manfredi M. Vigabatrin therapy for resistant partial epilepsies. Neuropsicofarmace 1993; 15: 105\u2013108.","journal-title":"Neuropsicofarmace"},{"key":"360484_CR3","first-page":"1694","volume":"314","author":"GFA. Harding","year":"1997","unstructured":"Harding GFA. Severe persistent visual field constriction associated with vigabatrin. Four possible mechanisms exist. Br Med J 1997; 314: 1694.","journal-title":"Br Med J"},{"key":"360484_CR4","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1212\/WNL.50.3.614","volume":"50","author":"GL Krauss","year":"1998","unstructured":"Krauss GL, Johnson MA, Miller NR. Vigabatrin-associated retinal cone system dysfunction. Electroretinogram and ophthalmologic findings. Neurology 1998; 50: 814\u2013819.","journal-title":"Neurology"},{"key":"360484_CR5","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1212\/WNL.52.6.1201","volume":"52","author":"CF Arndt","year":"1999","unstructured":"Arndt CF, Derambure P, Defoort-Dhellemmes S, Hache JC. Outer retinal dysfunction in patients treated with vigabatrin. Neurology 1999; 52: 1201\u20131205.","journal-title":"Neurology"},{"key":"360484_CR6","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/S0161-6420(99)90345-7","volume":"106","author":"H Daneshvar","year":"1999","unstructured":"Daneshvar H, Racette L, Coupland SG, Kertes PJ, Guberman A, Zakon D. Symptomatic and asymptomatic visual loss in patients taking vigabatrin. Ophthalmology 1999; 106: 1792\u20131798.","journal-title":"Ophthalmology"},{"key":"360484_CR7","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1212\/WNL.53.5.922","volume":"53","author":"R Kalvianien","year":"1999","unstructured":"Kalvianien R, Nousiainen I, Mantyjarvi M, Nikoskelainen E, Partanen J, Partanen K, Riekkinen P. Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field constriction. Neurology 1999; 53: 922\u2013926.","journal-title":"Neurology"},{"key":"360484_CR8","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/jnnp.67.6.716","volume":"67","author":"MC Lawden","year":"1999","unstructured":"Lawden MC, Eke T, Degg C, Harding GFA, Wild JM. Visual field defects associated with vigabatrin therapy. J Neurol, Neurosurg Psychiatry 1999; 67: 716\u2013722.","journal-title":"J Neurol, Neurosurg Psychiatry"},{"key":"360484_CR9","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1111\/j.1528-1157.1999.tb01599.x","volume":"40","author":"JM Wild","year":"1999","unstructured":"Wild JM, Martinez C, Reinshagen G, Harding GFA. Characteristics of a unique visual field defect attributed to vigabatrin. Epilepsia 1999; 40: 1784\u20131794.","journal-title":"Epilepsia"},{"key":"360484_CR10","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1212\/WNL.53.9.2082","volume":"53","author":"NR Miller","year":"1999","unstructured":"Miller NR, Johnson MA, Paul SR, Girkin CA, Perry JD, Endres M, Krauss GL Visual dysfunction in patients receiving vigabatrin. Clinical and electrophysiological findings. Neurology 1999; 53: 2082\u20132087.","journal-title":"Neurology"},{"issue":"Suppl.2","key":"360484_CR11","doi-asserted-by":"crossref","first-page":"2S52","DOI":"10.1177\/0883073891006002101","volume":"6","author":"C. Chiron","year":"1991","unstructured":"Catherine Chiron, Olivier Dulac, Daniel Beaumont, Leonardo Palacios, Nicole Pajot, John Mumford. Therapeutic Trial of Vigabatrin in Refractory Infantile Spasms. J. Child Neurol. 1991; 6(Suppl. 2): 2S52\u20132S59.","journal-title":"J. Child Neurol."},{"key":"360484_CR12","doi-asserted-by":"crossref","first-page":"95s","DOI":"10.1111\/j.1365-2125.1989.tb03468.x","volume":"27","author":"TR Browne","year":"1989","unstructured":"Browne TR, Mattson RH, Penry JK, Smith DB, Treiman DM, Wilder BJ, Ben-Menachchem E, Miketta RM, Sherry KM, Szabo GK. A multicentre study of vigabatrin for drug resistant epilepsy. Br J Clin Pharmacal 1989; 27: 95s\u2013100s.","journal-title":"Br J Clin Pharmacal"},{"key":"360484_CR13","first-page":"16","volume":"61","author":"EJ Hammond","year":"1989","unstructured":"Hammond EJ, Rangel RJ, Wilder BJ. Evoked potential monitoring of vigabatrin patients. Br J Clin Pract 1989; 61; 16\u201323.","journal-title":"Br J Clin Pract"},{"key":"360484_CR14","doi-asserted-by":"crossref","first-page":"61S","DOI":"10.1111\/j.1365-2125.1989.tb03463.x","volume":"27","author":"V Cosi","year":"1989","unstructured":"Cosi V, Callieco R, Galimberti CA, Manni R, Tartara A, Mumford JP, Perucca E. Effects of vigabatrin on evoked potentials in epileptic patients. Br J Clin Pharmacal 1989; 27: 61S\u201368S.","journal-title":"Br J Clin Pharmacal"},{"key":"360484_CR15","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1111\/j.1528-1157.1989.tb05829.x","volume":"30","author":"C Liegeois-Chauvel","year":"1989","unstructured":"Liegeois-Chauvel C, Marquis P, Gisselbrecht D, Pantieri R, Beaumont D, Chauvel P. Effects of long-term vigabatrin on somatosensory-evoked potentials in epileptic patients. Epilepsia 1989; 30; S23\u2013S25.","journal-title":"Epilepsia"},{"key":"360484_CR16","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1111\/j.1528-1157.1995.tb01674.x","volume":"36","author":"GFA Harding","year":"1995","unstructured":"Harding GFA, Jones LA, Tipper VJ, Betts TA, Mumford JP. Electro-retinogram, pattern electroretinogram and visual evoked potential assessment in patients receiving vigabatrin. Epilepsia 1995a; 36: S108.","journal-title":"Epilepsia"},{"key":"360484_CR17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1528-1157.1995.tb01661.x","volume":"36","author":"F Maugui\u00e8re","year":"1995","unstructured":"Maugui\u00e8re F, Chauvel P, Dewailly J, Dousse N. No Effect of long-term vigabatrin treatment on CNS conduction in epileptic patients: results of a multicenter study of somatosensory and visual evoked potentials. Epilepsia 1995; 36: 29.","journal-title":"Epilepsia"},{"key":"360484_CR18","doi-asserted-by":"crossref","first-page":"2S17","DOI":"10.1177\/0883073891006002051","volume":"6","author":"DJ Cannon","year":"1991","unstructured":"Cannon DJ, Butler WH, Mumford JP, Lewis PJ. Neuropathologic findings in patients receiving long-term vigabatrin therapy for chronic intractable epilepsy. J Child Neurol 1991; 6: 2S17\u20132S24.","journal-title":"J Child Neurol"},{"issue":"4","key":"360484_CR19","first-page":"427","volume":"31","author":"A Bayer","year":"1990","unstructured":"Bayer A, Zrenner E, Ried S and Schmidt D. Effects of anticonvulsant drugs on retinal function. Psychophysical and electrophysicological findings in patients with epilepsy. Invest Ophthalmol Vis Sci 1990; 31(4); 427.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"360484_CR20","first-page":"S973","volume":"39","author":"T Duckett","year":"1998","unstructured":"Duckett T, Brigell MG, Ruckh S. Electroretinographic changes are not associated with loss of visual function in paediatric patients following treatment with vigabatrin. Invest. Ophthalmol. Vis. Sci. 1998; 39: S973.","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"360484_CR21","first-page":"817","volume":"116","author":"K Ruether","year":"1998","unstructured":"Ruether K, Pung T, Kellner U, Schmitz B, Hartmann C, Seeliger M. Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin. Arch Ophthalmol 1998; 116: 817\u2013819.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"360484_CR22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1212\/WNL.55.3.347","volume":"55","author":"GFA Harding","year":"2000","unstructured":"Harding GFA, Wild JM, Robertson KA, Rietbrock S, Martinez C. Separating the Retinal Electrophysiologic Effects of Vigabatrin - Treatment Versus Field Loss. Neurology 2000; 55(3): 347\u2013352.","journal-title":"Neurology"},{"issue":"11","key":"360484_CR23","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1528-1157.2000.tb00117.x","volume":"41","author":"GFA Harding","year":"2000","unstructured":"Harding GFA, Wild JM, Robertson K, Lawden MC, Betts TA, Barber C and Barnes PMF. EOGs, ERGs, VEPs and Multifocal ERGs in Epileptic Patients Showing Visual Field Constriction. Epilepsia 2000; 41(11): 1420\u20131431.","journal-title":"Epilepsia"},{"key":"360484_CR24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1023\/A:1002045223358","volume":"97","author":"GFA Harding","year":"1999","unstructured":"Harding GFA, Robertson KA, Edson AS, Barnes P, Wild JM. Visual electrophysiological effect of a GABA transaminase blocker. Doc Ophthalmol 1999; 97: 179\u2013188.","journal-title":"Doc Ophthalmol"},{"key":"360484_CR25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF01214647","volume":"91","author":"MF Marmor","year":"1996","unstructured":"Marmor MF, Holder GE, Porciatti V, Trick GL, Zrenner E. Guidelines for basic pattern electroretinography. Doc Ophthalmol 1996; 91: 291\u2013298.","journal-title":"Doc Ophthalmol"},{"issue":"4","key":"360484_CR26","first-page":"91B51","volume":"40","author":"FB Bariel","year":"1999","unstructured":"Bariel FB, Delplace MP, De Toffol B, Majzoub F, Rossazza C. Electrophysiologic evaluation of visual disturbances associated with vigabatrin. Invest. Ophthalmol Vis Sci 1999; 40(4): 91B51.","journal-title":"Invest. Ophthalmol Vis Sci"},{"key":"360484_CR27","first-page":"1167","volume":"319","author":"RE. Appleton","year":"1999","unstructured":"Appleton RE. Guideline may help in prescribing vigabatrin. Br Med J 1999; 319: 1167.","journal-title":"Br Med J"},{"key":"360484_CR28","first-page":"171P","volume":"518P","author":"GFA Harding","year":"1999","unstructured":"Harding GFA, Robertson K, Holliday I, Jones L. Field-specific visual evoked potentials for assessment of peripheral field defect in a paediatric population. J Physiol 1999; 518P: 171P.","journal-title":"J Physiol"},{"key":"360484_CR29","first-page":"135","volume-title":"The macular and paramacular subcomponents of the pattern evoked response in human evoked potentials","author":"AM Halliday","year":"1979","unstructured":"Halliday AM, Barrett G, Blumhardt LD, Kriss A. The macular and paramacular subcomponents of the pattern evoked response in human evoked potentials. Lehmann D, Callaway E, eds. New York: Plenum 1979; 135\u2013151."}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1014643528474.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1014643528474\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1014643528474.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T03:55:27Z","timestamp":1753761327000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1014643528474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["360484"],"URL":"https:\/\/doi.org\/10.1023\/a:1014643528474","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"type":"print","value":"0012-4486"},{"type":"electronic","value":"1573-2622"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}